1489:
1432:
1571:
376:
73:
233:
1537:
1473:
1561:
369:
34:
1556:
1530:
1466:
362:
1385:
313:
1566:
345:
1523:
1459:
1357:
1367:
299:
273:
130:
1402:
951:
254:
61:
1390:
463:
385:
262:
667:
269:
1503:
1439:
94:
44:
27:
852:
811:
651:
443:
317:
743:
413:
354:
331:
1507:
1443:
103:
733:
723:
175:
292:
139:
1500:
1151:
927:
272:
was halted in Feb 2013. In
September 2014, a second phase III trial focussing on treating
1496:
1396:
257:(BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and
1550:
1306:
1107:
1052:
977:
937:
857:
751:
397:
389:
1296:
1281:
1261:
1251:
1230:
1146:
1087:
1072:
1042:
1022:
1017:
992:
972:
967:
962:
912:
902:
892:
842:
837:
832:
761:
646:
630:
533:
523:
518:
493:
433:
1362:
1352:
1291:
1276:
1266:
1256:
1235:
1220:
1205:
1200:
1195:
1170:
1123:
1102:
1097:
1092:
1082:
1077:
1062:
1037:
1027:
1007:
987:
982:
947:
942:
932:
922:
917:
887:
877:
847:
801:
796:
786:
771:
756:
728:
713:
698:
693:
688:
656:
599:
594:
584:
564:
543:
538:
508:
428:
1488:
1431:
1322:
1301:
1286:
1271:
1215:
1210:
1190:
1185:
1156:
1130:
1067:
1047:
1032:
1012:
1002:
957:
907:
897:
872:
867:
862:
827:
822:
791:
776:
718:
708:
703:
683:
620:
615:
604:
574:
569:
513:
488:
473:
458:
453:
423:
214:
114:
1225:
1057:
882:
781:
766:
625:
579:
553:
548:
528:
503:
498:
483:
478:
448:
418:
293:"Statement On A Nonproprietary Name Adopted By The USAN Council: Tabalumab"
20:
635:
558:
468:
438:
276:, was terminated early as the study failed to meet its primary endpoint.
1112:
997:
56:
1337:
258:
159:
49:
150:
358:
1511:
1447:
240:
1345:
1335:
1315:
1244:
1178:
1169:
1138:
810:
742:
676:
405:
396:
213:
174:
169:
149:
129:
113:
93:
88:
72:
67:
55:
43:
33:
26:
332:"Press Release Archive - Press Release Archives"
102:
1572:Antineoplastic and immunomodulating drug stubs
1420:Now dropped by Lilly due to lack of efficacy.
1531:
1467:
370:
346:"Lilly Halts Tabalumab Development for Lupus"
8:
19:
1538:
1524:
1474:
1460:
1342:
1175:
402:
377:
363:
355:
261:malignancies. Tabalumab was developed by
138:
1562:Drugs developed by Eli Lilly and Company
284:
18:
314:"BAFF Antibody: Tabalumab, LY2127399"
7:
1485:
1483:
1428:
1426:
158:
1510:. You can help Knowledge (XXG) by
1446:. You can help Knowledge (XXG) by
14:
1487:
1430:
316:. Lilly USA, LLC. Archived from
192:
186:
268:A phase III clinical trial for
1557:Drugs not assigned an ATC code
204:
198:
180:
1:
300:American Medical Association
274:systemic lupus erythematosus
1588:
1482:
1425:
170:Chemical and physical data
1567:Monoclonal antibody stubs
1380:
230:
255:B-cell activating factor
253:(LY 2127399) is an anti-
1442:–related article is a
464:Camidanlumab tesirine
386:Monoclonal antibodies
263:Eli Lilly and Company
1139:Chimeric + humanized
668:Nivolumab/relatlimab
270:rheumatoid arthritis
1440:monoclonal antibody
28:Monoclonal antibody
23:
16:Monoclonal antibody
1407:Never to phase III
853:Certolizumab pegol
820:Immunosuppressive:
320:on 12 August 2013.
1519:
1518:
1455:
1454:
1417:
1416:
1376:
1375:
1331:
1330:
1165:
1164:
1120:Immune activation
612:Immune activation
414:Immunosuppression
348:. 2 October 2014.
248:
247:
1579:
1540:
1533:
1526:
1501:immunomodulatory
1491:
1484:
1476:
1469:
1462:
1434:
1427:
1343:
1176:
734:Zolimomab aritox
724:Telimomab aritox
403:
379:
372:
365:
356:
350:
349:
342:
336:
335:
328:
322:
321:
310:
304:
303:
297:
289:
244:
243:
236:
225:
223:
206:
200:
194:
188:
182:
162:
142:
106:
24:
22:
1587:
1586:
1582:
1581:
1580:
1578:
1577:
1576:
1547:
1546:
1545:
1544:
1481:
1480:
1423:
1418:
1413:
1412:
1397:Clinical trials
1372:
1327:
1311:
1240:
1161:
1152:Rozanolixizumab
1140:
1134:
1126:
1115:
928:Lulizumab pegol
806:
738:
672:
392:
383:
353:
344:
343:
339:
330:
329:
325:
312:
311:
307:
295:
291:
290:
286:
282:
239:
237:
234:(what is this?)
231:
221:
219:
209:
203:
197:
191:
185:
165:
145:
125:
109:
84:
17:
12:
11:
5:
1585:
1583:
1575:
1574:
1569:
1564:
1559:
1549:
1548:
1543:
1542:
1535:
1528:
1520:
1517:
1516:
1497:antineoplastic
1492:
1479:
1478:
1471:
1464:
1456:
1453:
1452:
1435:
1415:
1414:
1411:
1410:
1409:
1408:
1405:
1394:
1388:
1382:
1381:
1378:
1377:
1374:
1373:
1371:
1370:
1365:
1360:
1355:
1349:
1347:
1340:
1333:
1332:
1329:
1328:
1326:
1325:
1319:
1317:
1313:
1312:
1310:
1309:
1304:
1299:
1294:
1289:
1284:
1279:
1274:
1269:
1264:
1259:
1254:
1248:
1246:
1242:
1241:
1239:
1238:
1233:
1228:
1223:
1218:
1213:
1208:
1203:
1198:
1193:
1188:
1182:
1180:
1173:
1167:
1166:
1163:
1162:
1160:
1159:
1154:
1149:
1143:
1141:
1136:
1135:
1117:
1116:
1110:
1105:
1100:
1095:
1090:
1085:
1080:
1075:
1070:
1065:
1060:
1055:
1050:
1045:
1040:
1035:
1030:
1025:
1020:
1015:
1010:
1005:
1000:
995:
990:
985:
980:
975:
970:
965:
960:
955:
952:+hyaluronidase
945:
940:
935:
930:
925:
920:
915:
910:
905:
900:
895:
890:
885:
880:
875:
870:
865:
860:
855:
850:
845:
840:
835:
830:
825:
816:
814:
808:
807:
805:
804:
799:
794:
789:
784:
779:
774:
769:
764:
759:
754:
748:
746:
740:
739:
737:
736:
731:
726:
721:
716:
711:
706:
701:
696:
691:
686:
680:
678:
674:
673:
671:
670:
660:
659:
654:
649:
639:
638:
633:
628:
623:
618:
608:
607:
602:
597:
592:
587:
582:
577:
572:
567:
562:
556:
551:
546:
541:
536:
531:
526:
521:
516:
511:
506:
501:
496:
491:
486:
481:
476:
471:
466:
461:
456:
451:
446:
441:
436:
431:
426:
421:
409:
407:
400:
394:
393:
384:
382:
381:
374:
367:
359:
352:
351:
337:
323:
305:
283:
281:
278:
246:
245:
228:
227:
217:
211:
210:
207:
201:
195:
189:
183:
178:
172:
171:
167:
166:
164:
163:
155:
153:
147:
146:
144:
143:
135:
133:
127:
126:
124:
123:
119:
117:
111:
110:
108:
107:
99:
97:
91:
90:
86:
85:
83:
82:
78:
76:
70:
69:
65:
64:
59:
53:
52:
47:
41:
40:
39:Whole antibody
37:
31:
30:
15:
13:
10:
9:
6:
4:
3:
2:
1584:
1573:
1570:
1568:
1565:
1563:
1560:
1558:
1555:
1554:
1552:
1541:
1536:
1534:
1529:
1527:
1522:
1521:
1515:
1513:
1509:
1506:article is a
1505:
1502:
1498:
1493:
1490:
1486:
1477:
1472:
1470:
1465:
1463:
1458:
1457:
1451:
1449:
1445:
1441:
1436:
1433:
1429:
1424:
1421:
1406:
1404:
1401:
1400:
1398:
1395:
1392:
1389:
1387:
1384:
1383:
1379:
1369:
1366:
1364:
1361:
1359:
1356:
1354:
1351:
1350:
1348:
1344:
1341:
1339:
1336:Inflammatory
1334:
1324:
1321:
1320:
1318:
1314:
1308:
1307:Tildrakizumab
1305:
1303:
1300:
1298:
1295:
1293:
1290:
1288:
1285:
1283:
1280:
1278:
1275:
1273:
1270:
1268:
1265:
1263:
1260:
1258:
1255:
1253:
1250:
1249:
1247:
1243:
1237:
1234:
1232:
1229:
1227:
1224:
1222:
1219:
1217:
1214:
1212:
1209:
1207:
1204:
1202:
1199:
1197:
1194:
1192:
1189:
1187:
1184:
1183:
1181:
1177:
1174:
1172:
1168:
1158:
1155:
1153:
1150:
1148:
1145:
1144:
1142:
1137:
1133:
1132:
1129:
1125:
1121:
1114:
1111:
1109:
1108:Vobarilizumab
1106:
1104:
1101:
1099:
1096:
1094:
1091:
1089:
1086:
1084:
1081:
1079:
1076:
1074:
1071:
1069:
1066:
1064:
1061:
1059:
1056:
1054:
1053:Spartalizumab
1051:
1049:
1046:
1044:
1041:
1039:
1036:
1034:
1031:
1029:
1026:
1024:
1021:
1019:
1016:
1014:
1011:
1009:
1006:
1004:
1001:
999:
996:
994:
991:
989:
986:
984:
981:
979:
978:Pembrolizumab
976:
974:
971:
969:
966:
964:
961:
959:
956:
953:
949:
946:
944:
941:
939:
938:Mogamulizumab
936:
934:
931:
929:
926:
924:
921:
919:
916:
914:
911:
909:
906:
904:
901:
899:
896:
894:
891:
889:
886:
884:
881:
879:
876:
874:
871:
869:
866:
864:
861:
859:
858:Crizanlizumab
856:
854:
851:
849:
846:
844:
841:
839:
836:
834:
831:
829:
826:
824:
821:
818:
817:
815:
813:
809:
803:
800:
798:
795:
793:
790:
788:
785:
783:
780:
778:
775:
773:
770:
768:
765:
763:
760:
758:
755:
753:
752:Andecaliximab
750:
749:
747:
745:
741:
735:
732:
730:
727:
725:
722:
720:
717:
715:
712:
710:
707:
705:
702:
700:
697:
695:
692:
690:
687:
685:
682:
681:
679:
675:
669:
665:
662:
661:
658:
655:
653:
650:
648:
644:
641:
640:
637:
634:
632:
629:
627:
624:
622:
619:
617:
613:
610:
609:
606:
603:
601:
598:
596:
593:
591:
588:
586:
583:
581:
578:
576:
573:
571:
568:
566:
563:
560:
557:
555:
552:
550:
547:
545:
542:
540:
537:
535:
532:
530:
527:
525:
522:
520:
517:
515:
512:
510:
507:
505:
502:
500:
497:
495:
492:
490:
487:
485:
482:
480:
477:
475:
472:
470:
467:
465:
462:
460:
457:
455:
452:
450:
447:
445:
442:
440:
437:
435:
432:
430:
427:
425:
422:
420:
416:
415:
411:
410:
408:
404:
401:
399:
398:Immune system
395:
391:
390:immune system
387:
380:
375:
373:
368:
366:
361:
360:
357:
347:
341:
338:
333:
327:
324:
319:
315:
309:
306:
301:
294:
288:
285:
279:
277:
275:
271:
266:
264:
260:
256:
252:
242:
235:
229:
218:
216:
212:
179:
177:
173:
168:
161:
157:
156:
154:
152:
148:
141:
137:
136:
134:
132:
128:
121:
120:
118:
116:
112:
105:
101:
100:
98:
96:
92:
87:
80:
79:
77:
75:
71:
68:Clinical data
66:
63:
60:
58:
54:
51:
48:
46:
42:
38:
36:
32:
29:
25:
1512:expanding it
1494:
1448:expanding it
1437:
1422:
1419:
1297:Risankizumab
1282:Lebrikizumab
1262:Clazakizumab
1252:Anrukinzumab
1231:Tralokinumab
1147:Otelixizumab
1127:
1119:
1118:
1088:Tregalizumab
1073:Tislelizumab
1043:Satralizumab
1023:Rontalizumab
1018:Retifanlimab
993:Plozalizumab
973:Pateclizumab
968:Pascolizumab
963:Ozoralizumab
913:Lampalizumab
903:Inebilizumab
893:Fontolizumab
843:Camrelizumab
838:Benralizumab
833:Atezolizumab
819:
762:Clenoliximab
663:
647:Bertilimumab
642:
631:Tremelimumab
611:
589:
534:Mavrilimumab
524:Lirentelimab
519:Lerdelimumab
494:Fresolimumab
434:Atorolimumab
412:
340:
326:
318:the original
308:
287:
267:
250:
249:
238:
232:
104:1143503-67-6
1393:from market
1363:Lemalesomab
1358:Fanolesomab
1353:Besilesomab
1292:Perakizumab
1277:Mirikizumab
1267:Gevokizumab
1257:Bimekizumab
1236:Ustekinumab
1221:Secukinumab
1206:Fezakinumab
1201:Canakinumab
1196:Briakinumab
1171:Interleukin
1124:Dostarlimab
1103:Visilizumab
1098:Vedolizumab
1093:Vatelizumab
1083:Toralizumab
1078:Tocilizumab
1063:Teclistamab
1038:Samalizumab
1028:Rovelizumab
1008:Ravulizumab
988:Pidilizumab
983:Pexelizumab
948:Ocrelizumab
943:Natalizumab
933:Mepolizumab
923:Ligelizumab
918:Letolizumab
888:Etrolizumab
878:Epratuzumab
848:Cedelizumab
802:Vapaliximab
797:Teneliximab
787:Lumiliximab
772:Gomiliximab
757:Basiliximab
729:Vepalimomab
714:Nerelimomab
699:Gavilimomab
694:Faralimomab
689:Elsilimomab
664:Combination
657:Zanolimumab
652:Ontamalimab
600:Ulocuplumab
595:Tezepelumab
585:Sifalimumab
565:Pamrevlumab
544:Morolimumab
539:Metelimumab
509:Lanadelumab
444:Avdoralimab
429:Anifrolumab
226: g·mol
89:Identifiers
1551:Categories
1323:Lokivetmab
1316:Veterinary
1302:Spesolimab
1287:Olokizumab
1272:Ixekizumab
1216:Guselkumab
1211:Fletikumab
1191:Brazikumab
1186:Bermekimab
1157:Sutimlimab
1131:Ibalizumab
1068:Teplizumab
1048:Siplizumab
1033:Ruplizumab
1013:Reslizumab
1003:Quilizumab
958:Omalizumab
908:Itolizumab
898:Frexalimab
873:Efalizumab
868:Eculizumab
863:Daclizumab
828:Aselizumab
823:Apolizumab
792:Priliximab
777:Infliximab
719:Odulimomab
709:Maslimomab
704:Inolimomab
684:Afelimomab
621:Durvalumab
616:Ipilimumab
605:Varlilumab
575:Relatlimab
570:Placulumab
514:Lenzilumab
489:Emapalumab
474:Cemiplimab
459:Brodalumab
454:Bleselumab
424:Adalimumab
280:References
215:Molar mass
140:PQP8VH3MJW
115:ChemSpider
95:CAS Number
1403:Phase III
1391:Withdrawn
1368:Sulesomab
1245:Humanized
1226:Sirukumab
1058:Talizumab
883:Erlizumab
812:Humanized
782:Keliximab
767:Galiximab
626:Nivolumab
590:Tabalumab
580:Sarilumab
554:Oleclumab
549:Namilumab
529:Lirilumab
504:Ianalumab
499:Golimumab
484:Eldelumab
479:Dupilumab
449:Belimumab
419:Abrilumab
251:Tabalumab
21:Tabalumab
744:Chimeric
636:Urelumab
559:Oxelumab
469:Carlumab
439:Avelumab
388:for the
241:(verify)
74:ATC code
1338:lesions
1113:TGN1412
998:PRO 140
176:Formula
1386:WHO-EM
1128:Other:
259:B cell
160:D10083
57:Target
45:Source
1495:This
1438:This
1346:Mouse
1179:Human
677:Mouse
643:Other
406:Human
296:(PDF)
190:10008
50:Human
1508:stub
1504:drug
1444:stub
202:2032
196:1724
184:6518
151:KEGG
131:UNII
122:none
81:none
62:BAFF
35:Type
1499:or
224:.08
222:252
220:146
1553::
1399::
1122::
666::
645::
614::
417::
298:.
265:.
208:38
1539:e
1532:t
1525:v
1514:.
1475:e
1468:t
1461:v
1450:.
954:)
950:(
561:§
378:e
371:t
364:v
334:.
302:.
205:S
199:O
193:N
187:H
181:C
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.